"A paper that Young, a biologist at the Massachusetts Institute of Technology in Cambridge, had published inCell in 2012 on how a protein called c-Myc spurs tumor growth was among 50 high-impact papers chosen for scrutiny by the Reproducibility Project: Cancer Biology."
That hardly sounds like "every single scientific paper ever published".
You are correct; I was being hyperbolic. But still, not sure Nature/Science/Cell is a high enough standard for "anyone should be able to replicate with little effort" -- lots of "non-late-game" results that aren't necessarily ready for industry applications get published in those venues (which, I guess I've been arguing, is a good thing.)
That hardly sounds like "every single scientific paper ever published".